Clindamycin for Bacterial Vaginosis
For non-pregnant women with BV, use clindamycin cream 2% (one full applicator intravaginally at bedtime for 7 days) as a recommended first-line option, though metronidazole regimens are slightly more effective. 1
Treatment Regimens by Clinical Context
Non-Pregnant Women
Recommended Regimens (in order of efficacy):
- Metronidazole 500 mg orally twice daily for 7 days (most effective)
- Metronidazole gel 0.75%, one full applicator (5g) intravaginally once daily for 5 days
- Clindamycin cream 2%, one full applicator (5g) intravaginally at bedtime for 7 days 1
Alternative Regimens (lower efficacy):
- Clindamycin 300 mg orally twice daily for 7 days 1
- Clindamycin ovules 100g intravaginally once at bedtime for 3 days 1
The CDC guidelines explicitly state that vaginal clindamycin cream is less efficacious than metronidazole regimens, but it remains a recommended option 1. Recent research confirms that oral clindamycin 300 mg twice daily for 7 days achieves comparable cure rates (68.1%) to oral metronidazole 2, 3.
Pregnant Women
For symptomatic pregnant women, use oral clindamycin 300 mg twice daily for 7 days 1. This is critical: avoid clindamycin vaginal cream during pregnancy as three trials demonstrated increased adverse events including prematurity and neonatal infections 1.
For high-risk pregnant women (prior preterm delivery):
- Screen and treat at first prenatal visit
- Use metronidazole 250 mg orally three times daily for 7 days OR
- Clindamycin 300 mg orally twice daily for 7 days 1
Special Circumstances
Metronidazole allergy or intolerance: Clindamycin cream or oral clindamycin is the preferred alternative 1
Recurrent BV: Extended metronidazole regimen is first-line, but if ineffective, consider clindamycin alternatives 4
Critical Counseling Points
For clindamycin cream/ovules:
- Oil-based formulation weakens latex condoms and diaphragms 1
- Apply at bedtime to minimize leakage
- Some leakage is common (55.4% experience it) but usually not bothersome 5
Treatment expectations:
- No follow-up needed if symptoms resolve 1
- Recurrence is common (up to 50% within 1 year) 4
- Partner treatment does NOT improve outcomes and is not recommended 1, 6
Emerging Evidence
A newer single-dose bioadhesive clindamycin 2% gel showed 70.5% clinical cure rates at test-of-cure with excellent tolerability 7. This formulation maintains vaginal concentrations for 24-72 hours and demonstrated rapid symptom resolution 8. While promising, this is not yet widely available and current guidelines still recommend the 7-day regimen.
Clinical Algorithm
- Confirm BV diagnosis (≥3 of 4 Amsel criteria or Nugent score 7-10)
- Assess pregnancy status - if pregnant, use oral clindamycin only
- Check for metronidazole contraindications (allergy, intolerance, alcohol use concerns)
- If metronidazole appropriate: Use metronidazole first (higher efficacy)
- If metronidazole not suitable: Use clindamycin cream 2% for 7 nights OR oral clindamycin 300 mg twice daily for 7 days
- Counsel on barrier method interference if using vaginal formulations
- Advise return only if symptoms recur - no routine follow-up needed